Linked Data API

Show Search Form

Search Results

1628301
registered interest false more like this
date remove maximum value filtermore like thismore than 2023-05-16
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Advanced Therapy Medicinal Products more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of reviewing the way the National Institute for Health and Care Excellence and NHS England evaluate and adopt Advanced Therapy Medicinal Products as technologies with the potential to deliver significant health gains over long periods of time. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 185240 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-05-25more like thismore than 2023-05-25
answer text <p>The National Institute of Health and Care Excellence (NICE) recently carried out a comprehensive review of its methods and processes for health technology evaluation to ensure that they were appropriate to emerging new technologies such as advanced therapeutic medicinal products (ATMPs). NICE published its updated health technology evaluation manual in January 2022 and has introduced a number of changes that ensure that its appraisal processes are suitable for emerging new medicines, including a broader severity modifier and changes to better respond to uncertainty. There are no plans for a further assessment of NICE’s processes for evaluating ATMPs.</p><p> </p><p>NICE’s methods and processes have been proven to be suitable for ATMPs where companies are willing to price their products in a way that represents value to the taxpayer. NICE has recommended 80% of the ATMPs it has evaluated for use by the National Health Service and they are now available for the treatment of NHS patients, including through the Cancer Drugs Fund and managed access agreements negotiated between the NHS and the manufacturer.</p>
answering member constituency Colchester more like this
answering member printed Will Quince more like this
question first answered
less than 2023-05-25T12:35:12.837Zmore like thismore than 2023-05-25T12:35:12.837Z
answering member
4423
label Biography information for Will Quince more like this
tabling member
3960
label Biography information for Henry Smith more like this
1627239
registered interest false more like this
date less than 2023-05-12more like thismore than 2023-05-12
answering body
Department for Business and Trade more like this
answering dept id 214 more like this
answering dept short name Business and Trade more like this
answering dept sort name Business and Trade more like this
hansard heading Electric Vehicles: Manufacturing Industries more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Business and Trade, what steps her Department is taking to support electric vehicle manufacturing. more like this
tabling member constituency Crawley more like this
tabling member printed
Henry Smith remove filter
uin 184806 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2023-05-31more like thismore than 2023-05-31
answer text <p>The Automotive Transformation Fund (ATF) aims to support the creation of an internationally competitive electric vehicle supply chain in the UK. The Government continues to work with industry via the ATF to unlock strategic investments in gigafactories, motors and drives, power electronics, and fuel cell systems.</p><p> </p><p>In the coming months, after engagement with industry, the Government will build on the ATF and the long-term Advanced Propulsion Centre R&amp;D programme to take decisive action to ensure future investment in the manufacturing of zero emission vehicles.</p> more like this
answering member constituency Wealden more like this
answering member printed Ms Nusrat Ghani more like this
question first answered
less than 2023-05-31T11:46:47.937Zmore like thismore than 2023-05-31T11:46:47.937Z
answering member
4460
label Biography information for Ms Nusrat Ghani more like this
tabling member
3960
label Biography information for Henry Smith more like this